Ignite Creation Date:
2024-05-06 @ 2:30 PM
Last Modification Date:
2024-10-26 @ 1:32 PM
Study NCT ID:
NCT04337658
Status:
NOT_YET_RECRUITING
Last Update Posted:
2020-04-08
First Post:
2020-01-11
Brief Title:
Anti-HER2 Therapy FulvestrantCapecitabine in Women With HR HER2 Non-visceral Metastases Stage IV Breast Cancer
Sponsor:
Organization:
Second Affiliated Hospital School of Medicine Zhejiang University